PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY
May 1, 2019, 00:00
10.1016/j.jval.2019.04.380
https://www.valueinhealthjournal.com/article/S1098-3015(19)30572-8/fulltext
Title :
PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30572-8&doi=10.1016/j.jval.2019.04.380
First page :
Section Title :
Open access? :
No
Section Order :
10028